his.sePublikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Expression of FXYD3 Protein in Relation to Biological and Clinicopathological Variables in Colorectal Cancers
Linkoping Univ, Dept Oncol, Inst Clin & Expt Med, SE-58185 Linkoping, Sweden .
Linkoping Univ, Dept Oncol, Inst Clin & Expt Med, SE-58185 Linkoping, Sweden .
Vrinnevi Univ Hosp, Dept Surg, Norrkoping, Sweden .
Univ Heidelberg, Inst Clin Radiol & Nucl Med, Univ Hosp Mannheim, Heidelberg, Germany .
Vise andre og tillknytning
2009 (engelsk)Inngår i: Chemotherapy, ISSN 0009-3157, E-ISSN 1421-9794, Vol. 55, nr 6, s. 407-413Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Background: FXYD3 is up-/down-regulated in different types of cancers. We examined FXYD3 expression in colorectal cancers and its relationship to biological and clinicopathological variables. Patients and Methods: Expression of FXYD3 protein was immunohistochemically examined in distant normal mucosa (n = 34), adjacent normal mucosa (n = 72), primary tumour (n = 150) and lymph node metastasis (n = 35) from colorectal cancer patients. Results: FXYD3 was highly expressed in primary tumour compared to adjacent normal mucosa (p = 0.02). FXYD3 was or tended to be positively related to the expression of ras (p = 0.02), p53 (p = 0.06), legumain (p = 0.02) and proliferating cell nuclear antigen (p = 0.03). Moreover, there was a higher frequency of strong FXYD3 expression in Dukes A-C tumours than in D tumours (p = 0.04). The strong FXYD3 expression tended to predict worse survival in the patients with Dukes A + B tumour (p = 0.07), while there was no such tendency in the patients with Dukes C + D tumour (p = 0.94). The tumours located in the colon had a higher degree of FXYD3 expression than the tumours located in the rectum (p = 0.05). Conclusion: The FXYD3 was associated with certain biological variables and may be involved in the development of the relative earlier stages of colorectal cancers. Copyright (C) 2009 S. Karger AG, Basel

sted, utgiver, år, opplag, sider
S. Karger, 2009. Vol. 55, nr 6, s. 407-413
Emneord [en]
Colorectal cancer, FXYD3, Immunohistochemistry
Identifikatorer
URN: urn:nbn:se:his:diva-6939DOI: 10.1159/000263227ISI: 000272605600003PubMedID: 19955746Scopus ID: 2-s2.0-70849137093OAI: oai:DiVA.org:his-6939DiVA, id: diva2:578843
Tilgjengelig fra: 2012-12-19 Laget: 2012-12-19 Sist oppdatert: 2017-12-06bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekstPubMedScopus

Personposter BETA

Zhang, Hong

Søk i DiVA

Av forfatter/redaktør
Zhang, Hong
Av organisasjonen
I samme tidsskrift
Chemotherapy

Søk utenfor DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 18 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf